Table 2 Methylation status of Zp and Rp in EBV-associated cell lines and tumors
| EBV-associated cell lines and tumors |
Zp methylation status (Methylated CpG sites, %) |
Rp methylation status (methylated CpG sites, %) |
|---|---|---|
| Cell lines | ||
| Akata | 67% | 59% |
| B95-8 | 17% | 36% |
| C666-1 | 75% | 99% |
| Namalwa | 46% | 53% |
| Raji | 60% | 87% |
| Rael | 67% | 83% |
| Wan | 18% | 29% |
| Nude mice-passaged tumors | ||
| C15 | 68% | 96% |
| C18 | 56% | 59% |
| Tumors | ||
| NPC | ||
| NPC1 | 58% | 97% |
| NPC2 | 92% | 88% |
| NPC12 | 70% | 87% |
| BL | ||
| BL3 | 62% | 80% |
| BL5 | 53% | 82% |
| BL10 | 67% | 82% |
| PTLD | ||
| PTLD2 | 32% | 64% |
| PTLD4a | 44% | 85% |
| PTLD8 | 22% | 70% |
| PTLD10 | 47% | 73% |
| PTLD19 | 53% | 80% |
| PTLD20 | 75% | 80% |
